Literature DB >> 19752359

The complete supraannular concept: in vivo hemodynamics of bovine and porcine aortic bioprostheses.

Daniel J Ruzicka1, Ina Hettich, Andrea Hutter, Sabine Bleiziffer, Catalin C Badiu, Robert Bauernschmitt, Ruediger Lange, Walter B Eichinger.   

Abstract

BACKGROUND: Complete supraannular placement of an aortic bioprosthesis is one approach to optimize the hemodynamic result of an aortic valve replacement. It is achieved with the combination of a special valve design and the supraannular sewing technique with noneverted mattress sutures. We evaluated 5 bioprostheses designed for complete supraannular placement to assess potential hemodynamic differences caused by factors (eg, valve material) other than implantation position. METHODS AND
RESULTS: In 336 patients (mean age, 72.0+/-7.1 years; 143 women), hemodynamics including mean pressure gradients, effective orifice areas, and indices and incidence of patient-prosthesis mismatch were evaluated 6 months after surgery. Annulus diameter was measured during surgery. Patients received the Carpentier Edwards Perimount Magna (Magna, n=169), the Medtronic Mosaic (Mosaic, n=46), the Mosaic Ultra (Ultra, n=17), the SJM Epic Supra (Epic, n=46), and the Sorin Soprano (Soprano, n=58). For small annulus sizes (<23 mm), the mean pressure gradients of the Magna (11.82+/-4.8 mm Hg) were significantly lower than the Mosaic (16.04+/-6.1 mm Hg) and the Ultra (22.0+/-4.1 mm Hg), and the Soprano (13.3+/-5.2 mm Hg) was hemodynamically superior to the Ultra. For medium (23 to 24 mm) and large (>24 mm) annulus sizes, the mean pressure gradients of the Magna were lower than the Epic (10.0+/-3.5 mm Hg versus 14.9+/-6.4 mm Hg; 9.9+/-4.0 mm Hg versus 18.6+/-12.7 mm Hg). Furthermore, in patients with large annulus size, the mean pressure gradients of the Soprano (11.4+/-3.8 mm Hg) were lower compared with the Epic (18.5+/-12.7 mm Hg). Severe patient-prosthesis mismatch was observed more frequently in patients with the Mosaic (12/46; 26.1%) and the Ultra (3/17; 17.6%) prostheses.
CONCLUSIONS: Complete supraannular placement cannot prevent high pressure gradients or patient-prosthesis mismatch thoroughly, but the choice of a bovine prosthesis can optimize hemodynamic performance.

Entities:  

Mesh:

Year:  2009        PMID: 19752359     DOI: 10.1161/CIRCULATIONAHA.109.844332

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

Review 1.  The Use of Biological Heart Valves.

Authors:  Sami Kueri; Fabian A Kari; Rafael Ayala Fuentes; Hans-Hinrich Sievers; Friedhelm Beyersdorf; Wolfgang Bothe
Journal:  Dtsch Arztebl Int       Date:  2019-06-21       Impact factor: 5.594

2.  St. Jude Medical Trifecta™ aortic valve perioperative performance in 200 patients.

Authors:  Eduard Permanyer; Arnaldo-Javier Estigarribia; Alejandro Ysasi; Enrique Herrero; Omar Semper; Rafael Llorens
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-03

Review 3.  Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.

Authors:  Shuyu Wen; Ying Zhou; Wai Yen Yim; Shijie Wang; Li Xu; Jiawei Shi; Weihua Qiao; Nianguo Dong
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

4.  Clinical and echocardiographic outcomes after implantation of the Trifecta aortic bioprosthesis: an initial single-centre experience.

Authors:  Angelo M Dell'Aquila; Dominik Schlarb; Stefan R B Schneider; Jürgen R Sindermann; Andreas Hoffmeier; Gerrit Kaleschke; Sven Martens; Andreas Rukosujew
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-15

5.  Early outcomes and hemodynamics after implantation of the Trifecta aortic bioprosthesis.

Authors:  Hiroyuki Seo; Yasushi Tsutsumi; Osamu Monta; Satoshi Numata; Sachiko Yamazaki; Shohei Yoshida; Takaaki Samura; Hirokazu Ohashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-12-17

6.  Late clinical outcomes of aortic valve replacement with Carpentier-Edwards pericardial valves.

Authors:  Hyoung Woo Chang; Wook Sung Kim; Joong Hyun Ahn; Keumhee C Carriere; Dong Seop Jeong; Yang Hyun Cho; Kiick Sung; Pyo Won Park
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

7.  Stented bioprostheses in aortic position.

Authors:  J Cremer; J Schöttler; R Petzina; G Hoffmann
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2012

8.  Glutaraldehyde and 2,3-butanediol treatment of bovine pericardium for aortic valve bioprosthesis in sheep: a preliminary study.

Authors:  Kai Ren; Weixun Duan; Zhuowen Liang; Bo Yu; Buying Li; Zhengxiao Jin; Yimin Zhao; Chao Xue; Shiqiang Yu; Jincheng Liu; Xufeng Wei
Journal:  Ann Transl Med       Date:  2020-12

9.  Comparison of Long-term Performance of Bioprosthetic Aortic Valves in Sweden From 2003 to 2018.

Authors:  Michael Persson; Natalie Glaser; Johan Nilsson; Örjan Friberg; Anders Franco-Cereceda; Ulrik Sartipy
Journal:  JAMA Netw Open       Date:  2022-03-01

Review 10.  Bioprosthetic Aortic Valve Degeneration: a Review from a Basic Science Perspective.

Authors:  Tiago R Velho; Rafael Maniés Pereira; Frederico Fernandes; Nuno Carvalho Guerra; Ricardo Ferreira; Ângelo Nobre
Journal:  Braz J Cardiovasc Surg       Date:  2022-05-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.